|
DCTN6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.24369999999908E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.967000E-04 |
| Normal-vs-Stage2 |
1.675730E-03 |
| Normal-vs-Stage3 |
7.51460000000259E-05 |
| Normal-vs-Stage4 |
1.7504199999907E-05 |
| Stage1-vs-Stage2 |
5.172400E-01 |
| Stage1-vs-Stage3 |
1.484240E-01 |
| Stage1-vs-Stage4 |
9.706000E-02 |
| Stage2-vs-Stage3 |
7.087200E-01 |
| Stage2-vs-Stage4 |
4.381600E-01 |
| Stage3-vs-Stage4 |
6.368600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.58270000000438E-05 |
| Normal-vs-AfricanAmerican |
4.491000E-01 |
| Normal-vs-Asian |
1.561650E-03 |
| Caucasian-vs-AfricanAmerican |
3.702400E-02 |
| Caucasian-vs-Asian |
7.170200E-01 |
| AfricanAmerican-vs-Asian |
1.042610E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.22290000000602E-05 |
| Normal-vs-Female |
2.635200E-04 |
| Male-vs-Female |
2.950000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.375000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.185450E-04 |
| Normal-vs-Age(61-80Yrs) |
1.605190E-04 |
| Normal-vs-Age(81-100Yrs) |
1.168650E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.276600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.387600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.713000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.992400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.120000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.419200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.042400E-01 |
| Classical-VS-Follicular |
7.847400E-01 |
| Classical-VS-Other |
4.244000E-01 |
| Classical-VS-Normal |
2.156900E-04 |
| Tall-VS-Follicular |
3.586800E-01 |
| Tall-VS-Other |
7.236000E-01 |
| Tall-VS-Normal |
1.202470E-03 |
| Follicular-VS-Other |
5.032200E-01 |
| Follicular-VS-Normal |
9.236000E-03 |
| Other-VS-Normal |
3.053800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.66310000000647E-05 |
| Normal-vs-N1 |
1.89852999999962E-05 |
| N0-vs-N1 |
1.753410E-01 |
|
|
